Skip to main content

Table 1 Baseline Characteristics of the Original METS Cohort (2506) by Sitea (mean ± SD, %)

From: Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol

 

Ghana (n = 500)

South Africa (n = 504)

Jamaica (n = 500)

Seychelles (n = 500)

USA (n = 502)

Age (y)

34.3 ± 6.7

33.4 ± 5.8

34.4 ± 6.1

36.1 ± 5.6

35.3 ± 6.3

BMI (kg/m2)

24.1 ± 4.6

27.5 ± 8.1

26.5 ± 6.4

27.1 ± 5.7

31.9 ± 8.5

Fat Mass (kg)

18.5 ± 9.2

29.0 ± 16.0

24.7 ± 13.4

25.8 ± 11.1

37.7 ± 18.3

Body Fat (%)

28.3 ± 10.3

36.8 ± 11.4

31.0 ± 11.4

33.1 ± 9.2

39.1 ± 11.0

Plasma Glucose (mg/dL)

99.7 ± 12.1

84.0 ± 23.0

93.1 ± 9.4

100.7 ± 29.1

100.1 ± 34.8

% Carbohydrate (%Energy)

65.8 ± 10.4

54.9 ± 11.8

58.5 ± 8.5

51.2 ± 9.3

45.9 ± 9.4

% Protein (%Energy)

11.9 ± 4.0

16.6 ± 4.8

14.8 ± 4.1

18.4 ± 4.7

15.5 ± 4.1

% Fat (%Energy)

21.7 ± 9.2

26.4 ± 9.3

25.6 ± 6.6

28.4 ± 7.6

36.6 ± 7.0

Fiber (g/day)

25.0 ± 9.7

8.7 ± 4.0

16.5 ± 8.4

13.5 ± 6.7

14.2 ± 7.1

Soluble Fiber (g/day)

6.0 ± 2.8

2.9 ± 1.4

4.9 ± 2.7

3.9 ± 2.1

4.6 ± 2.4

Insoluble Fiber (g/day)

18.9 ± 7.5

5.8 ± 2.9

11.6 ± 6.1

9.6 ± 5.1

9.5 ± 5.38

Obesity (%)

9.8

32.1

27.6

26.4

52.4

Diabetes (%)

1.0

2.4

0.2

3.4

9.6

  1. aSites are presented according to their level of Epidemiologic Transition, using Human Development Index rankings. Diabetes, random glucose > 140 mg/dL or currently taking diabetes medication